InMed Pharmaceuticals files Form 425
InMed Pharmaceuticals filed a Form 425.
Related stories
Australian energy stocks drop over 4%
Australian energy stocks fell more than 4%, tracking lower oil prices.
M impact | EQUITY | Nov 03, 2026, 12:30 AM UTC
Global market picture: S&P 500 -0.33%, Nasdaq 100 -1.08%; EUR/USD +0.07%, WTI -7.56%
Global market picture. US index futures: S and P futures is down 0.33 percent, Nasdaq futures is down 1.08 percent, Dow futures is up 0.5 percent and Russell futures is up 0.07 per
M impact | EQUITY | Nov 03, 2026, 12:30 AM UTC
Samsung Biologics Signs Contract With Global Pharma Company
Samsung Biologics signed a contract to manufacture products for a global pharmaceutical company.
M impact | EQUITY | Nov 03, 2026, 12:27 AM UTC
Oracle Set to Issue Stock at an 11% Discount
Bloomberg News reports Oracle is set to issue stock at an 11% discount.
M impact | EQUITY | Nov 03, 2026, 12:26 AM UTC
Oracle to Issue Stock at an 11% Discount
Bloomberg News reports that Oracle is set to issue stock at an 11% discount.
M impact | EQUITY | Nov 03, 2026, 12:26 AM UTC
Toromont Industries Reports Quarterly Results
Toromont Industries reported results for the quarter ended September 30. The supplied report contains no financial figures.
M impact | EQUITY | Nov 03, 2026, 12:23 AM UTC